Authors
Latest:
Cultural Transformations a Necessity to Support Complex Therapeutics Through Development and ManufacturingPresident and CEO of Pharmaceutics International, Inc. (Pii), John Fowler, reacts to the agility and flexibility needed to support the development and manufacture of today's complex biotherapeutics.
Latest:
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT: OVERCOMING CHALLENGES IN ORAL DELIVERYObesity is a significant global health challenge that requires lifestyle changes and effective pharmacological treatments to overcome. Human glucagon-like peptide 1 (GLP-1) analogs, also called incretin mimetics, have emerged as a promising obesity treatment option. Additionally, oral GLP-1 formulations represent a groundbreaking advance in obesity treatment, offering greater patient comfort and adherence to expand the therapeutic market.
Latest:
Federal Equipment Company: Supporting CDMO Operations Through Training, Parts, and EquipmentAdam Covitt, President of Federal Equipment Company, discusses how the company enables CDMO successes with its Techceuticals and PharmParts business brands.
Latest:
Implementation of Autocorners Algorithm for Retrospective Process MonitoringThe authors present a simple-to-use Microsoft Excel-based statistical tool that uses cumulative sum techniques to aid retrospective understanding of data trends.
Latest:
Implementation of Autocorners Algorithm for Retrospective Process MonitoringThe authors present a simple-to-use Microsoft Excel-based statistical tool that uses cumulative sum techniques to aid retrospective understanding of data trends.
Latest:
Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1: A Science-Based Holistic ApproachWebinar Date/Time: Tuesday, February 28th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Latest:
Integrated Pre-Formulation Studies for Fast Advancement of Drug Candidates to Human Clinical StudiesLooking for a fast pathway to an investigational new drug application (IND) for your new drug candidates? This webcast will discuss strategies to select the most developable molecules and quickly develop an IND-ready formulation within 8–12 weeks using real-world case studies. Live: Wednesday, April 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Apr. 15, 2021 Register free
Latest:
Booming Biotech: Five Start-Ups to Watch in CambridgeAccording to recent figures, Cambridge’s technology sector is booming and the city is emerging as a hub for biotech companies.
Latest:
Optimizing Equipment Availability for Capsule FillersLearn what the common equipment bottlenecks are and how engineering developments can maximize equipment availability. Experts will provide insight into how to minimize cycle, set-up, and changeover times and how to define optimal parameters for each process step. Live: Tuesday, Mar. 24, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET On demand available after airing until Mar. 24, 2021 Register free
Latest:
Determination of Related Substances in Pemetrexed Disodium (Form-IV) in Bulk Drug Samples by HPLCThe authors describe the development of a stability-indicating reverse-phase high-performance liquid chromatographic (RP?HPLC) method for the quantitative determination of potential genotoxic impurities present in pemetrexed disodium (form-IV). The chromatographic separation was achieved on a RP?HPLC column (Zorbax SB-Phenyl, Agilent) at ambient temperature with gradient elution using mobile phase A (trifluoroacetic acid [TFA] in water) and mobile phase B (TFA in acetonitrile).
Latest:
Global Considerations for Oligonucleotide Synthesis SolutionsWebinar Date/Time: Thu, Oct 24, 2024 10:00 AM EDT
